TimesSquare Capital Management LLC Sells 59,372 Shares of Encompass Health Corporation $EHC

TimesSquare Capital Management LLC cut its stake in Encompass Health Corporation (NYSE:EHC) by 14.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 338,269 shares of the company’s stock after selling 59,372 shares during the quarter. TimesSquare Capital Management LLC owned about 0.34% of Encompass Health worth $41,482,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. WPG Advisers LLC purchased a new position in shares of Encompass Health during the first quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in Encompass Health by 179.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after acquiring an additional 307 shares in the last quarter. Park Place Capital Corp purchased a new position in shares of Encompass Health during the 2nd quarter worth approximately $72,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after acquiring an additional 115 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.4%

Shares of NYSE EHC opened at $115.62 on Wednesday. The firm’s 50 day moving average price is $123.25 and its 200-day moving average price is $119.75. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market cap of $11.63 billion, a PE ratio of 21.86, a P/E/G ratio of 2.20 and a beta of 0.91.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The company had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio is presently 14.37%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president directly owned 18,846 shares in the company, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Truist Financial upped their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. Bank of America lifted their target price on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Finally, Zacks Research raised Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Three investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $142.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.